← Leaderboards
Weibo Luo
Ut Southwestern Medical Center
$2,833,715
Attributed
$2,833,715
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370.6K · FY2013–23$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,833,715 · 3
By mechanism
R01$1,845,464 · 1
R00$746,991 · 1
K99$241,260 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Suzanne Daniela Conzen$8,641,344
- Vikram D. Kodibagkar$3,711,146
- Ivan Pedrosa$7,238,451
- Angelique Wright Whitehurst$6,833,234
- William L Kraus$26,921,621
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroNew Therapeutic TargetHypoxiaInsightMouse ModelNeoplasm MetastasisGenetic TranscriptionGrowthCollaborationsHypoxia Inducible Factor 1Mammary NeoplasmsMalignant NeoplasmsMediatingMolecularBioinformaticsEpigenetic ProcessAngiogenesisCell SurvivalCancer BiologyBhlh-Pas Factor HlfBreast Cancer CellHypoxia Inducible FactorMalignant Breast NeoplasmPlay
Grant awards (10)
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression$363,164
R01 · FY2023 · CA · contact PI
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression$370,575
R01 · FY2022 · CA · contact PI
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression$370,575
R01 · FY2021 · CA · contact PI
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression$370,575
R01 · FY2020 · CA · contact PI
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression$370,575
R01 · FY2019 · CA · contact PI
The role of JMJD2C in HIF-1 activation and breast cancer progression$249,000
R00 · FY2017 · CA · contact PI
The role of JMJD2C in HIF-1 activation and breast cancer progression$248,992
R00 · FY2016 · CA · contact PI
The role of JMJD2C in HIF-1 activation and breast cancer progression$248,999
R00 · FY2015 · CA · contact PI
The role of JMJD2C in HIF-1 activation and breast cancer progression$120,630
K99 · FY2014 · CA · contact PI
The role of JMJD2C in HIF-1 activation and breast cancer progression$120,630
K99 · FY2013 · CA · contact PI